Osler Radiation Oncology 2021 The Osler Institute utilized state-of-the-art equipment to record our Live Virtual Webinar March 2021 comprehensive Radiation Oncology Review Course and bring it to you! these Video files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection, watch or listen to on your phone, computer, or tablet – your learning experience is almost like being at the live activity, but without travel costs and time away from your practice.
Included with each online review is a downloadable copy of the syllabus that corresponds to the Video lectures for your use while viewing or as a free-standing study or clinical practice guide.
This review provides senior trainees and/or clinicians in practice a comprehensive update of clinical knowledge and helps prepare them for their Radiation Oncology exams (the initial certification and MOC). Emphasis is on evidence-based medicine and board-relevant standards of care as well as new concepts, treatments, and imaging approaches.
The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and chemotherapy adjuvant treatments, follow-up treatment and evaluation, patterns of failure, and normal tissue effects including complications; all of these areas are addressed. The review also covers the basic principles of radiobiology and physics that are relevant to clinical practice.
Objectives
At the conclusion of this course, each participant should be able to perform the following tasks for all cancers of the eleven ABR defined component areas:
- Describe the anatomy, epidemiology/etiologic agents, and natural history
- Explain the pathology and use of tumor markers
- Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)
- Summarize potential treatment modalities including optimum beam and radiation sources, volume and dose calculations, as well as fractionation
- Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects
- Discuss the use of multimodality therapies, including sequence, interactions, and specific agents
- Describe brachytherapy applications and issues for all disease sites
- Outline the use of palliative care for brain, hepatic and skeletal lesions, plus various obstructive scenarios
- Implement a basic program of ethics, patient safety, and quality assurance in clinical practice
Faculty and Topics
Dukagjin Blakaj, MD, Ph.D.
Assistant Professor of Radiation Oncology,
Ohio State University
Head and Neck Cancer I – III
Steven Lin, MD, Ph.D.
Associate Professor of Radiation Oncology,
MD Anderson Cancer Center
Early Stage NSCLC, Locally Advanced NSCLC, Small Cell Lung Cancer, Rare Mediastinal Tumors
Victor Mangona, MD
Practicing Radiation Oncologist, Texas Center for Proton Therapy, Irvine, TX
Pediatric Brain Tumors, Brain Stem Glioma, Medulloblastoma, Intracranial Germ Cell Tumors, Ependymoma, Pediatric Gliomas, Pediatric CNS Questions, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Ewing’s Sarcoma, Pediatric Solid Questions
Todd Swanson, MD, PhD†
Assistant Professor of Radiation Oncology, University of Texas, Galveston
CNS Overview, Primary CNS Malignancies, CNS Metastasis of Brain, CNS Metastasis Spine, Benign disorders of CNS, Palliative Care, †Course Planning Committee
Chad Tang, MD
Assistant Professor
Radiation Oncology
Investigational Cancer Therapeutics Translational Molecular Pathology
Early/Intermediate-Risk Prostate Cancer, High Risk and Metastatic Prostate Cancer, Adjuvant/Salvage Prostate Cancer
Jillian R. Gunther, MD PhD
Assistant Professor
The University of Texas
MD Anderson Cancer Center
Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Solitary Plasmacytoma
Scott R. Silva MD, Ph.D.
Assistant Professor
University of Louisville
School of Medicine
Endometrial Cancer, Cervical Cancer, Vulvar Cancer
Tarita Thomas, MD, Ph.D., MBA
Early Stage Breast Cancer, Locally Advanced Breast Cancer, Carcinoma-in-situ and Misc (DCIS)
Navine Hanna, MD, MPH
Radiation Oncology Specialists Advent Health Medical Group
Palm Coast, FL
Esophageal Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer, Anal Cancer, Liver Cancer, Pancreatic Ampullary Cancer, Bile Duct Cancer
Paras Khandhar, MD, FAAP
Attending, Pediatric Critical Care Medicine, Beaumont Children’s
Lead Inpatient Physician Informaticist – Beaumont Health
Associate Professor of Pediatrics, Oakland University William Beaumont School of Medicine
EVIDENCED BASED MEDICINE (EBM), PATIENT SAFETY & QUALITY IMPROVEMENT
Release Date: March 2021
